Kidney Diseases  >>  Isentress (raltegravir)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isentress (raltegravir) / Merck (MSD)
ANRS153TREVE, NCT01453192: Renal Transplantation and Raltegravir in HIV-Infected Patients

Completed
3
27
Europe
Raltegravir, Isentress
ANRS, Emerging Infectious Diseases, Merck Sharp & Dohme LLC
HIV-1 Infection, Chronic Renal Insufficiency
11/15
11/15

Download Options